Carey Douglas Kessler & Ruby PLLC
General
Cases12
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechMech Eng, ManufChemical
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 11/15/24 | ORDER GRANTING MOTIONS TO WITHDRAW AS COUNSEL (ECF NOS. [394] , [395] ). Signed by Chief District Judge Thomas S. Kleeh on 11/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 11/15/2024) | |
| 10/31/24 | ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 378 ). Ms. Anderson shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 10/31/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 10/31/2024) | |
| 10/21/24 | ORDER STIPULATION AND ORDER. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 10/21/2024) | |
| 10/21/24 | STIPULATION AND ORDER REGARDING CASE MANAGEMENT. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/21/2024) | |
| 10/18/24 | FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 11/18/2024. Rule 26 Meeting Report due by 12/2/2024. Discovery due by 12/18/2024. Signed by Chief District Judge Thomas S Kleeh on 10/18/2024. (dk) (Entered: 10/18/2024) | |
| 09/06/24 | Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024) | |
| 08/28/24 | JOINT STIPULATION AND ORDER TO MODIFY SCHEDULE. (Pretrial Order due by 4/2/2025, Final Pretrial Conference set for 4/9/2025 at 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh, Bench Trial set for 4/14/2025 at 09:30 AM (5 days reserved) in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh.) Signed by Chief District Judge Thomas S. Kleeh on 08/28/2024. (snc) (Entered: 08/28/2024) | |
| 07/26/24 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/26/2024) | |
| 07/16/24 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024) | |
| 08/09/22 | The following patents were Instituted by PTAB:
Patent US10828310 in IPR2022-00517 |